Skip to content
Medical Health Aged Care

Paternal gut health may affect the physical and mental health of offspring

The Florey 2 mins read

Gut health affects sperm  

Florey researchers have shown, for the first time, that a father’s gut health plays a role in offspring physiology and behaviour. 

Co-lead author and Research Lead of The Florey’s Mental Health Mission, Professor Anthony Hannan, said the findings in mice, as well as his lab’s previous work, have potential implications for men planning families, suggesting that their nutrition and health could affect their future children. 

“We’re used to hearing that women need to look after their physical health for the sake of their baby,” Professor Hannan said. “Our discoveries in mice, and emerging findings in humans, suggest that it’s important that men do so too.” 

The latest research, published in Brain, Behavior, and Immunity, found the depletion of the gut microbiota of male mice was associated with changes in their sperm that significantly affected offspring. 

“Male mice were given oral antibiotics to deplete their gut microbiota. We discovered that this resulted in epigenetic changes in sperm that could alter neurodevelopment and associated brain function in offspring.” 

Male and female offspring in the study had reduced body weight and their gut length was reduced.  Female offspring also showed changes in anxiety and depressive-like behaviours. 

Co-lead author, Dr Carolina Gubert said that the composition of microbial populations in the gut in mice and humans can be affected by many environmental factors such as diet, exercise and stress. In earlier studies at The Florey, Professor Hannan’s team showed that mouse offspring are affected by changes in their father’s sperm caused by bacterial infections and virus-like challenges, as well as diet, exercise and stress. 

The study’s first author, PhD student Bethany Masson said: “Human gut microbiota function is similar to mice, and we believe our findings may have broader implications for human health. Men’s health, diet and behaviour before conception may play an important role in the health of their children.”  

Bethany Masson, Dr Carolina Gubert and Professor Hannan’s research team are following up these discoveries at The Florey. 


About us:

Notes to editor:  

The Florey is Australia’s leading brain research institute with a focus on improving the lives of people with neurological and psychiatric conditions. The Florey’s research missions are centred around dementia, epilepsy, mental health and developing ways to promote brain health and repair the brain. These missions are strengthened by The Florey’s expertise in neurotherapeutics, neuroimaging, synaptic biology and systems neuroscience. With 600 researchers, The Florey is the largest research centre of its kind in the southern hemisphere. 

Find out more about us on our website: www.florey.edu.au  


Contact details:

Kathryn Powley, Media and Communications Manager 

kathryn.powley@florey.edu.au | 0456 666 271 

Media

More from this category

  • Government Federal, Medical Health Aged Care
  • 08/11/2024
  • 06:30
Immunisation Foundation of Australia

Whooping cough outbreak worst on record

Whooping cough outbreak worst on record More than 45,000 cases of the infectious lung disease expected by year end Australia is in the grip…

  • Contains:
  • Medical Health Aged Care
  • 07/11/2024
  • 23:11
Zenas BioPharma

Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences

WALTHAM, Mass, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the Company’s participation at the following healthcare investor conferences:Guggenheim’s Inaugural Healthcare Innovation Conference on November 12, 2024, in Boston, MAJefferies London Healthcare Conference on November 19, 2024 presentation at 4:00 p.m. to 4:25 p.m. GDT, in LondonCiti’s 2024 Global Healthcare Conference on December 3, 2024 presentation at 9:30 a.m. to 10:10 a.m. ET, in Miami, FLEvercore ISI HealthCONx Conference on December 4,…

  • Medical Health Aged Care
  • 07/11/2024
  • 23:11
Tilray Brands, Inc.

Tilray Medical Announces Positive Results from Study on Oral Cannabis Extract for Chemotherapy-Induced Emesis

SYDNEY, Australia, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray Brands") (NASDAQ: TLRY and TSX: TLRY) and a global leader in medical cannabis empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, is pleased to announce the final results of a new scientific study their team has supported titled, "Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV)."This randomized, placebo-controlled trial aimed to test the effectiveness of an oral cannabis extract in adults suffering from CINV despite standard anti-nausea treatments. Participants received capsules containing…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.